Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARGATE: Herpes Zoster Vaccine and CMV-specific T Cells in Glioblastoma
NCT07546669Phase 4Not yet recruiting
- Sponsor
- Universitätsmedizin Essen
- Start
- Jan 2027
- Primary completion
- Dec 2029
- Modality
- Vaccines & Immunotherapeutics, Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs)
01
Overview
A Phase 4 trial of Zoster vaccine recombinant, autologous Cytomegalovirus-specific Cytotoxic T-lymphocytes in glioblastoma (GBM), sponsored by Universitätsmedizin Essen. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
Zoster vaccine recombinantautologous Cytomegalovirus-specific Cytotoxic T-lymphocytes
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT07546669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07546669.